Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interventions to Improve Memory in Patients With Multiple Sclerosis
NCT00062972Phase 3Withdrawn
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil, glucose in multiple sclerosis (MS), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Planned start Sep 1999; status: withdrawn.
02
Drugs
donepezilglucose
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00062972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062972.